期刊文献+

紫杉醇与mTOR抑制剂雷帕霉素联合抑制非小细胞肺癌增殖 被引量:1

Inhibition of paclitaxel combined with mTOR inhibitor Rapamycin on proliferation of NSCLC cells
下载PDF
导出
摘要 目的研究紫杉醇对非小细胞肺癌A549细胞mTOR信号通路的影响,以及紫杉醇与mTOR抑制剂雷帕霉素的联合作用。方法在紫杉醇和/或雷帕霉素处理细胞后,采用流式细胞术分析细胞周期和细胞凋亡;免疫印迹技术分析信号分子表达与磷酸化;采用细胞计数法检测细胞增殖。结果 (5×10^(-6))g/L紫杉醇作用24 h可诱导(31.26±2.52)%细胞发生凋亡;但随紫杉醇浓度增加,细胞凋亡率下降而G_2/M期阻滞效应增加。紫杉醇对mTOR分子的表达无影响,但与其结合的raptor和rictor,以及抗凋亡分子survivin表达随浓度增加而增加,mTOR下游分子S6K1磷酸化也被上调。雷帕霉素与紫杉醇同时或在紫杉醇作用后加入培养体系可增强其对肿瘤增殖的抑制作用,并促进紫杉醇诱导细胞凋亡。结论紫杉醇对A549细胞mTOR信号通路的活化有上调作用,mTOR抑制剂与雷帕霉素可协同抑制非小细胞肺癌增殖。 Objective To study the effect of paclitaxel on mTOR signaling pathway in NSCLC cell A549 and the combination effects of paclitaxel and mTOR inhibitor Rapamycin. Methods Cell cycle and apoptosis were detected by flow cytometry after cells treated by paclitaxel with or without Rapamycin. The expression or phosphorylation of cell signaling molecules were determinated by Western blot, and inhibition rate of tumor cell proliferation was detected by cell counting. Results The apoptosis rate of A549 treated by 5 x 10 -6g/L paclitaxel for 24 hours was (31.26 ___2.52) %. The apoptosis induction effect of higher concentration of paclitaxel decreased, but the cell mitosis blocking effect increased with the concentration. Paclitaxel did not affect the expression of mTOR, but the expression of two molecules bounded with mTOR, raptor and rictor was up-regulated by paclitaxel.Paclitaxel could also increase the mount of survivin and the phosphorylation of S6K1. The apoptosis inducing effect and the antitumor effect of paclitaxel were enhanced by Rapamycin which adding in the cell culture medium with paclitaxel simuteniusly or after the pretreatment for 16 hours. Conclusion Paclitaxel activates mTOR associated pathway. Inhibition of mTOR with Rapamycin can enhance the anti-tumor effect of paclitaxel, and promote the apoptosis induced by palitaxel.
出处 《同济大学学报(医学版)》 CAS 2010年第4期39-42,65,共5页 Journal of Tongji University(Medical Science)
基金 吉林省科技厅资助项目(200705406)
关键词 紫杉醇 非小细胞肺肿瘤 雷帕霉素 paclitaxel NSCLC Rapamycin
  • 相关文献

参考文献9

  • 1Yang Z, Kenny AE, Birto DA, et al. Cells satisfy the mitotic checkpoint in taxol and do so faster in concentrations that stabilize syntelic attachments [J].J Cell Biol, 2009, 186 (5) : 675 - 684.
  • 2Bekier ME, Fischbach R, Lee J, et al. Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit[J]. Mol Cancer Ther, 2009,8(6) : 1646 - 1654.
  • 3Annovazzi L, Mellai M, Caldera V, et al. mTOR, S6 and AKT expression in relation to proliferation and apoptosis/autopliagy in glioma[J].Anticancer Res, 2009,29(8) : 3087 -3094.
  • 4Kris MG. How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care[J]. Oncologist, 2005,10 (Suppl 2) : 23 - 29.
  • 5Courtney KD, Corcoran RB, Engelman JA. The PI3 K path way as drug target in human cancer [J]. J Clin Oncol, 2010,28(6) : 1075 - 1083.
  • 6Greenberg VL, Zimmer SG. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism [J]. Oncogene, 2005,24 (30) : 4851 - 4860.
  • 7O'Reilly KE, Warycha M, Daries MA, et al. Phosphorylated 4E-BP1 is associated with poor survival in melanoma[J]. Clin Cancer Res, 2009,15(8) : 2872-2878.
  • 8黄嘉佳,林桐榆.mTOR通路及其抑制剂抗肿瘤的研究进展[J].癌症,2007,26(12):1397-1403. 被引量:21
  • 9Konicek BW, Dumstorf CA, Graft JR. Targeting the eIF4F translation initiation complex for cancer therapy [J]. Cell Cycle,2008,7(16) : 2466-2471.

二级参考文献2

共引文献20

同被引文献13

  • 1Wohrer SS,Raderer M,Hejna M. Palliative chemothetapy for adwanced gastric cancer[J].{H}ANNALS OF ONCOLOGY,2004,(11):1585-1595.
  • 2Murayama T,Inokuchi M,Takagi Y. Relation between outcomes and localization of p-mTOR expression in gastric cancer[J].{H}British Journal of Cancer,2009,(05):782-788.
  • 3Oza AM,Elit L,Tsao MS. Phase Ⅱ study of temsitolimus in women with recurrent ot metastatic endometrial cancer:A trial of the NCIC Clinical Trials Group[J].{H}Journal of Clinical Oncology,2011,(24):3278-3285.
  • 4AL Batran SE,Ducreux M,Ohtsu A. mTOR as a therapentic target in patients with gastric cancer[J].{H}International Journal of Cancer,2012,(03):391-396.
  • 5Liu LZ,Zhou XD,Qian G. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70s6K1 pathway[J].{H}CANCER RESEARCH,2007,(13):6325-6332.
  • 6Miyazawa M,Yasuda M,Fujita M. Granulose cell tumor with activated mTOR HIF-1α-VEGF pathway[J].{H}Journal of Obstetrics and Gynaecology Research,2010,(02):448-453.
  • 7Miyazawa M,Yasuda M,Fujita M. Therapeutic strategy targeting the mTOR-HIF 1α-VEGF pathway in ovarian clear cell adenocarcinoma[J].{H}Pathology International,2009,(01):717-721.
  • 8Harada H,Itasaka S,Kizaka-Koudoh S. The Akt/mTOR pathway assures the synthesis of HIF-1α protein in a glucose-and teoxy genation-dependent manner in irradiated tumors[J].{H}Journal of Boilogical Chemisty,2009,(08):5332-5342.
  • 9李田,杨越波,孟丽荣,李小毛,许成芳,李征然.雷帕霉素抑制子宫内膜癌裸鼠移植瘤生长活体成像的观察[J].中华肿瘤防治杂志,2011,18(16):1221-1224. 被引量:4
  • 10许成芳,李小毛,李田,王小韵.雷帕霉素增强子宫内膜癌细胞对阿霉素的敏感性[J].中国病理生理杂志,2011,27(11):2090-2095. 被引量:5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部